Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Tadalafil tablets bulk supplier for pharma manufacturers

Tadalafil Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 2.5 mg, 5 mg, 10 mg, 20 mg and 40 mg(P. Hypertension)

Reference Brands: Cialis(US & EU),Adcirca(US)

Category: Sexual Wellness

Tadalafil inhibits phosphodiesterase type 5 (PDE5), increasing nitric oxide effects and blood flow to the penis, aiding erectile function. It also relaxes prostate muscles, relieving BPH symptoms. Benefits include rapid onset, long duration (up to 36 hours), convenience, and improved sexual performance and quality of life for men with ED or BPH.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Tadalafil tablets, marketed as Cialis, are approved in the US by the FDA and in the EU via EMA for erectile dysfunction (ED) and benign prostatic hyperplasia (BPH). Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews comprehensive clinical trial and manufacturing data, while the EMA ensures compliance with regional safety and quality standards.

Tadalafil Tablets — third party manufacturing & bulk supply

Tadalafil Tablets is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Tadalafil Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Tadalafil Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Tadalafil Tablets →
Back to Listing

Frequently Asked Questions

Tadalafil tablets is listed as Tablet in 2.5 mg, 5 mg, 10 mg, 20 mg and 40 mg(P. Hypertension). Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Tadalafil tablets is referenced against Cialis(US & EU),Adcirca(US). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Sildenafil Citrate Tablets

Strength:
25 mg, 50 mg, 100 mg; For pulmonary: 20 mg, 40 mg, 60 mg, 80 mg

Form: Tablet

Reference Brands: (US & EU): Viagra, Revatio (for pulmonary hypertension)

View Details
Vardenafil Tablet

Strength:
5 mg, 10 mg, 20 mg

Form: Tablet

Reference Brands: Levitra, Staxyn(US & EU)

View Details
Avanafil Tablets

Strength:
50 mg, 100 mg, 200 mg

Form: Tablet

Reference Brands: Stendra(US)

View Details
Alprostadil Injection

Strength:
10 µg and 20 µg

Form: Injection

Reference Brands: Caverject, Edex(US)

View Details
Mesterolone Tablets

Strength:
25 mg

Form: Tablet

Reference Brands: Proviron(US)

View Details
Flibanserin Tablet

Strength:
100 mg

Form: Tablet

Reference Brands: Addyi(US)

View Details
Bremelanotide Sq Injection

Strength:
1.75 mg

Form: Injection(SQ)

Reference Brands: Vyleesi (US)

View Details
Estrogen + Levonorgestrel. Patch

Strength:
50 μg estradiol + 10 mg levonorgestrel.

Form: Patch

Reference Brands: Climara(EU & US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.